Kiora Pharmaceuticals

Kiora Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company founded with the mission to develop and commercialize novel therapeutics aimed at treating orphan retinal diseases. The company focuses on improving sight in patients suffering from severe vision loss and addressing high unmet needs in ophthalmic health. Kiora Pharmaceuticals is publicly traded on the NASDAQ under the ticker symbol KPRX and serves a global market.

Notable affiliated individuals include key researchers and industry experts specializing in ophthalmology. The company has garnered significant attention from investors due to its innovative approach to treating rare retinal conditions. Key achievements include advancing several promising therapeutics through clinical development stages, demonstrating potential to significantly impact the quality of life for patients with severe vision impairments. Kiora Pharmaceuticals continues to make strides in ocular health, aiming to restore vision and improve overall eye health for patients worldwide.